Le Lézard
Classified in: Business
Subject: INO

Thinking about trading options or stock in Dave & Buster's, Quidel, AMC Entertainment, NetApp, or Ambarella?


NEW YORK, Sept. 10, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PLAY, QDEL, AMC, NTAP, and AMBA.

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report ? Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

SOURCE InvestorsObserver


These press releases may also interest you

at 07:48
Arçelik renames its global operations under one corporate brand "Beko"
Arçelik, the world's leading manufacturer of household appliances, announced today it will rename its global operations under one international...

at 07:45
Canada Life Investment Management Ltd. announces changes to certain mutual funds
Canada Life Investment Management Ltd. (CLIML) today announced changes to its mutual fund lineup that include soft capping and fee reductions for certain funds....

at 07:42
Inc & Co brand incspaces Announces ?1.5M Investment in Barcelona Office with European Expansion Plans & Global Pivot
New sites in Barcelona and Dublin are set to open this quarter, the latter...

at 07:42
Akastor ASA: Payment received of DRU award
Reference is made to Akastor ASA's (OSE: AKAST) announcement dated 18 April 2024 on the arbitration award issued in respect of the DRU contracts. Payment of the principal sums awarded, in total USD 108 million (exclusive interest), has now been...

at 07:35
HCA Healthcare Reports First Quarter 2024 Results
HCA Healthcare, Inc. today announced financial and operating results for the first quarter ended March 31, 2024. Key first quarter metrics (all percentage changes compare 1Q 2024 to 1Q 2023 unless otherwise noted): Revenues totaled $17.339...

at 07:35
AbbVie Reports First-Quarter 2024 Financial Results
Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable Impact of $0.08 Per Share Related to Acquired IPR&D and...

More news about Business...


News published on and distributed by: